Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$29.04 0.53 (1.86%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.44(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.32 - $47.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 208,796 351,548
Total Sell Value $3,656,226 $3,656,226 $7,121,778 $16,615,472
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 37 64
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 253
  Page 4 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 AS $37.00 $543,900 D/D (14,700) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 OE $1.61 $23,667 D/D 14,700 14,700     -
   Wicki Andreas Director   –       •      –    2013-07-22 4 AS $35.28 $703,508 I/I (19,938) 1,630,944     -
   Wicki Andreas Director   –       •      –    2013-07-19 4 AS $34.98 $1,959,524 I/I (56,020) 1,650,882     -
   Wicki Andreas Director   –       •      –    2013-07-18 4 AS $34.80 $140,662 I/I (4,042) 1,706,902     -
   Wicki Andreas Director   –       •      –    2013-07-17 4 AS $33.20 $714,398 I/I (21,518) 1,710,944     -
   Wicki Andreas Director   –       •      –    2013-07-16 4 AS $33.20 $11,620 I/I (350) 1,732,462     -
   Wicki Andreas Director   –       •      –    2013-07-15 4 AS $33.28 $1,601,833 I/I (48,132) 1,732,812     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-07-12 4 AS $32.00 $952,128 D/D (29,754) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-07-12 4 OE $1.61 $47,904 D/D 29,754 29,754     -
   Wicki Andreas Director   –       •      –    2013-07-11 4 AS $31.48 $2,518,416 I/I (80,000) 1,780,944     -
   Wicki Andreas Director   –       •      –    2013-07-05 4 AS $30.80 $1,355,961 I/I (44,021) 1,860,944     -
   Wicki Andreas Director   –       •      –    2013-07-03 4 AS $30.67 $1,533,300 I/I (50,000) 1,904,965     -
   Wicki Andreas Director   –       •      –    2013-07-02 4 AS $29.85 $1,808,820 I/I (60,597) 1,954,965     -
   Patou Gary Chief Medical Officer   •       –      –    2013-07-02 4 AS $30.00 $300,000 D/D (10,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-07-02 4 OE $1.61 $16,100 D/D 10,000 10,000     -
   Wicki Andreas Director   –       •      –    2013-07-01 4 AS $29.85 $114,952 I/I (3,851) 2,015,562     -
   Patou Gary Chief Medical Officer   •       –      –    2013-07-01 4 AS $29.25 $877,500 D/D (30,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-07-01 4 OE $1.61 $48,300 D/D 30,000 30,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-06-28 4 AS $28.05 $280,460 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-06-28 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Longenecker John P Phd Director   –       •      –    2013-06-28 4 AS $28.09 $56,178 D/D (2,000) 0     -
   Longenecker John P Phd Director   –       •      –    2013-06-28 4 OE $1.61 $3,220 D/D 2,000 2,000     -
   Stack David M President and CEO   •       •      –    2013-06-28 4 AS $28.73 $430,967 D/D (15,000) 2,573     -
   Stack David M President and CEO   •       •      –    2013-06-28 4 OE $1.61 $24,150 D/D 15,000 17,573     -

  253 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed